✦ LIBER ✦

41 Preliminary results of a randomized comparative phase III trial of topotecan (T) versus CAV as second-line therapy of small cell lung cancer (SCLC)

✍ Scribed by Schiller, J.H.; von Pawel, J.; Clarke, P.; Kleisbauer, J.P.; Dobbs, T.; Chrysson, N.; Dane, G.C.; Hudson, I.; DeWitte, M.; Fields, S.Z.

Book ID: 123469500
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 300 KB
Volume: 18
Category: Article
ISSN: 0169-5002
DOI: 10.1016/S0169-5002(97)89320-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Preliminary results of a randomised comp

Preliminary results of a randomised comparative phase III trial of topotecan versus CAV as second-line therapy of small cell lung cancer

✍ Clarke, P.; Schiller, J.H.; Von Pawel, J.; Kleisbauer, J.P.; Dobbs, T.; Chrysson 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 215 KB

A Randomized Phase II Trial of Oral Topo

A Randomized Phase II Trial of Oral Topotecan Versus Docetaxel in the Second-Line Treatment of Non–Small-Cell Lung Cancer

✍ Suzanne Jones; Dana Thompson; John Barton; Jeff Patton; Dianna Shipley; F. Antho 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 124 KB

Paclitaxel-cisplatin-etoposide (TEP) ver

Paclitaxel-cisplatin-etoposide (TEP) versus cisplatin-etoposide (EP) as first line treatment in small cell lung cancer (SCLC): a preliminary analysis of a multicenter randomized phase III trial

✍ D. Mavroudis; E. Papadakis; M. Veslemes; M. Agelidou; M. Toubis; A. Agelidou; J. 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Randomized Phase III Trial of Erlotinib

Randomized Phase III Trial of Erlotinib Versus Docetaxel As Second- or Third-Line Therapy in Patients With Advanced Non-Small-Cell Lung Cancer: Docetaxel and Erlotinib Lung Cancer Trial (DELTA)

✍ Kawaguchi, T.; Ando, M.; Asami, K.; Okano, Y.; Fukuda, M.; Nakagawa, H.; Ibata, 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 183 KB

9120 Second-line amrubicin vs topotecan

9120 Second-line amrubicin vs topotecan in extensive-disease small cell lung cancer (ED-SCLC) sensitive to first-line platinum-based chemotherapy: updated results of a randomized phase 2 trial

✍ Jotte, R.; Conkling, P.R.; Reynolds, C.; Shah, C.; Galsky, M.; Klein, L.; Fitzgi 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 69 KB

P-778 A phase II trial of carboplatin an

P-778 A phase II trial of carboplatin and irinotecan as first-line therapy for extensive stage small cell lung cancer (ES-SCLC): Preliminary results

✍ Laskin, J.; Shirley, B.; Dobbs, T.; Bi, J.; Carbone, D.; Johnson, D.; Sandler, A 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 141 KB